OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 02, 2014
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
March 02, 2014
Changes in company ownership shake up the CMO industry.
February 18, 2014
Thirteen companies are accepted for participation in the supply chain program.
February 02, 2014
CMOs may find opportunities in alternative expression services.
February 01, 2014
Contract manufacturing organizations that are established in key markets can provide a competitive edge.
Traditional project decision-making is compared with a QbD approach.
Geographic location, customs and drug-development regulations knowledge, and transportation infrastructure were factors in Catalent Pharma Solutions' selection of Shanghai for its clinical-trials supply facility.
The relatively low success rates for bio/pharmaceutical compounds in clinical development have prompted many organizations to explore ways of reducing risk in clinical development.
Increased competition from CMOs in Asia means that Western CMOs need to understand fundamental changes in the market.
Pharmaceutical companies are adopting multiple choice partnership strategies to meet the challenges of today's R&D instead of being focused primarily on internal development.